what are the vaccines for booster doses? For which audience? And how to benefit from it?

For which audience?

The Ministry of Health therefore followed the recommendations of the HAS by prioritizing the public to be vaccinated: people over 60, pregnant women, adults at risk of severe form and their entourage (from 6 months after the last booster shot). ); as well as people over 80, residents of nursing homes and USLDs and immunocompromised people (from 3 months after the last reminder or the last infection).

Among those aged 75 and over, 42% benefited from the second booster. But only a third of 65-74 year olds and barely 13% of 50-64 year olds. The 30-49 year olds who were 68% to have received the first reminder are only 2% to have had the second. And just 1% of 18-29 year olds.

However, it is now official: “a young person, without comorbidity, who regularly sees relatives in the target is therefore eligible” underlines a note from the Ministry of Health this week. And for people who have been recently infected, a period of three months before vaccination is recommended.

Why a recall?

The University Hospital Center (CHU) of Toulouse estimated in February 2022 that “the concentrations of antibodies necessary for protection against Omicron are 2.4 times higher than against Delta”. Hence the usefulness of this fourth injection, or even fifth if the first vaccination schedule took place very early.

According to health authorities and several epidemiologists, the beginning of a ninth wave, with the progression of the new BQ1.1 variant derived from Omicron, all the more justifies the need for the second booster to better protect against Covid.

Which vaccines?

As of November 28, 2 million booster doses against Covid have been administered since the launch of the campaign in early October, including 1.8 million with a bivalent vaccine. “The bivalent Covid-19 vaccines act against the initial strain of the Sars-CoV-2 coronavirus and against the Omicron variant of this virus and thus provide better protection”, specifies the Health Insurance.

It is mainly bivalent boosters from Pfizer that are administered (1.6 million doses out of the 2 million injections carried out since October 3).

The Moderna laboratory recently obtained marketing authorization for the bivalent form of the Spikevax vaccine in a single-dose vial. Sanofi’s vaccine, which also received authorization on November 11, is “highly anticipated”. These two vaccines should be available in early January.

End of stock monovalent vaccines are always used for people starting their vaccination course.

And for the children?

Since November 23, the delivery of Pfizer-BioNTech pediatric vaccines for 5-11 year olds (Comirnaty) has been temporarily suspended. This decision comes due to an expiry on November 30, 2022 of the bottles currently available. The Pfizer pediatric vaccine should be available to order again in December 2022, when the laboratory has obtained the extension of this expiry date, following the stability studies carried out.

Where to get vaccinated?

While most vaccination centers have closed, injections are now mainly carried out in the city: surgeries and pharmacies perform “85%”, according to the Ministry of Health. Despite the effectiveness of this local system until last spring, the president of the committee for monitoring and anticipating health risks, Brigitte Autran, pleads for the reopening of vaccination centers in order to catch up with the delay in the vaccination campaign. of this fall.

Is a prescription needed?

In fact, no need for a prescription, the Vitale card is enough. If you are eligible for a booster dose of vaccination against Covid-19, you can make an appointment “with your pharmacist, doctor or nurse, or at a vaccination center, in order to receive it”, indicates the General Directorate of Health (DGS).

Leave a Comment